nach oben

Metabolic Brain Disease

Erschienen in:

24.11.2017 | Original Article

Neuroprotective effects of nootkatone from Alpiniae oxyphyllae Fructus against amyloid-β-induced cognitive impairment

verfasst von: Bosai He, Fanxing Xu, Feng Xiao, Tingxu Yan, Bo Wu, Kaishun Bi, Ying Jia

Erschienen in: Metabolic Brain Disease | Ausgabe 1/2018

Einloggen, um Zugang zu erhalten

Abstract

The sesquiterpene nootkatone (NKT), isolated from Alpiniae oxyphyllae Fructus, was shown to possess protective effects on neurons. In our study, by using an Alzheimer’s disease (AD) model of mice induced by intracerebroventricular (i.c.v.) injection of Aβ_1–42 oligomers, we investigated the effects of NKT on memory impairment and further evaluated the pathological changes of mice. AD mice were treated by i.c.v. injection of NKT (at a dose of 0.02 mg/kg and 0.20 mg/kg) or vehicle (PBS) into the lateral ventricle once daily for 5 consecutive days. The behavioral tasks were performed, and levels of some biochemical indicators and histopathological changes of the brain were evaluated to elucidate the mechanism of NKT in the treatment of AD. The results revealed that NKT significantly improved the neurobehavioral performance of the AD mice in the Y-maze and Morris water maze tests. More importantly, NKT treatment decreased the malondialdehyde (MDA), Aβ as well as the acetylcholin esterase (AChE) levels in the mice brain, while increased the glutathione peroxidase (GSH-Px) levels with improved histopathological changes in the hippocampus. These findings provided evidences for the beneficial role of NKT in Aβ_1–42-induced mice AD model linking to anti-oxidative and anti-AChE activities with inhibitory effect against Aβ accumulation.

Ansari MA, Scheff SW (2010) Oxidative stress in the progression of Alzheimer disease in the frontal cortex. J Neuropathol Exp Neurol 69(2):155–167. https://doi.org/10.1097/NEN.0b013e3181cb5af4 CrossRefPubMedPubMedCentral

Butterfield DA, Drake J, Pocernich C, Castegna A (2001) Evidence of oxidative damage in Alzheimer's disease brain: central role for amyloid β-peptide. Trends Mol Med 7(12):548–554. https://doi.org/10.1016/S1471-4914(01)02173-6 CrossRefPubMed

Chami L, Buggiaprévot V, Duplan E, Delprete D, Chami M, Peyron JF, Checler F (2012) Nuclear factor-κB regulates β APP and β- and γ-secretases differently at physiological and supraphysiological Aβ concentrations. J Bio Chem 287(29):24573–24584. https://doi.org/10.1074/jbc.M111.333054 CrossRef

Chen P, Xiang L (2013) Acetylcholinesterase inhibitory activities of 48 traditional Chinese medicinal herbs. J Chin Pharm Sci 22:106–109

Chinese Pharmacopoeia Commission (2010) Pharmacopoeia of the People's Republic of China, vol 1. China Medical Science and Technology Press, Beijing

Craig LA, Hong NS, McDonald RJ (2011) Revisiting the cholinergic hypothesis in the development of Alzheimer's disease. Neurosci Biobehav Rev 35(6):1397–1409. https://doi.org/10.1016/j.neubiorev.2011.03.001 CrossRefPubMed

Davies KM, Deroles SC (2014) Prospects for the use of plant cell cultures in food biotechnology. Curr Opin Biotechnol 26:133–140. https://doi.org/10.1016/j.copbio.2013.12.010 CrossRefPubMed

He P, Ouyang X, Zhou S, Yin W, Tang C, Laudon M, Tian S (2013) A novel melatonin agonist Neu-P11 facilitates memory performance and improves cognitive impairment in a rat model of Alzheimer’disease. Horm Behav 64(1):1–7. https://doi.org/10.1016/j.yhbeh.2013.04.009 CrossRefPubMed

Ho SC, Liu JH, RY W (2003) Establishment of the mimetic aging effect in mice caused by D-galactose. Biogerontology 4(1):15–18. https://doi.org/10.1023/A:1022417102206 CrossRefPubMed

Ho GJ, Drego R, Hakimian E, Masliah E (2005) Mechanisms of cell signaling and inflammation in Alzheimer's disease. Curr Drug Targets Inflamm Allergy 4(2):247–256. https://doi.org/10.2174/1568010053586237 CrossRefPubMed

Hu W, Gray NW, Brimijoin S (2004) Amyloid-beta increases acetylcholinesterase expression in neuroblastoma cells by reducing enzyme degradation. J Neurochem 86(2):470–478. https://doi.org/10.1046/j.1471-4159.2003.01855.x CrossRef

Hynd MR, Scott HL, Dodd PR (2004) Glutamate-mediated excitotoxicity and neurodegeneration in Alzheimer's disease. Neurochem Int 45(5):583–585. https://doi.org/10.1016/j.neuint.2004.03.007 CrossRefPubMed

Ibach B, Haen E (2004) Acetylcholinesterase inhibition in Alzheimer's disease. Curr Pharm Design 10(3):231–251. https://doi.org/10.2174/1381612043386509 CrossRef

Javed H, Khan MM, Ahmad A, Vaibhav K, Ahmad ME, Khan A, Ashafaq M, Islam F, Siddiqui MS, Safhi MM, Islam F (2012) Rutin prevents cognitive impairments by ameliorating oxidative stress and neuro in ammation in rat model of sporadic dementia of Alzheimer type. Neuroscience 210:340–345. https://doi.org/10.1016/j.neuroscience.2012.02.046 CrossRefPubMed

Kharrazi H, Vaisi-Raygani A, Rahimi Z, Tavilani H, Aminian M, Pourmotabbed T (2008) Association between enzymatic and non-enzymatic antioxidant defense mechanism with apolipoprotein E genotypes in Alzheimer disease. Clin Biochem 41(12):932–936. https://doi.org/10.1016/j.clinbiochem.2008.05.001 CrossRefPubMed

Koo BS, Lee WC, Chang YC, Kim CH (2004) Protective effects of alpinae oxyphyllae fructus (Alpinia oxyphylla Miq.) water-extracts on neurons from ischemic damage and neuronal cell toxicity. Phytother Res 18(2):142–148. https://doi.org/10.1002/ptr.1382 CrossRefPubMed

Kubo M, Matsuda H, Suo T, Yamanaka J, Sakanaka M, Yoshimura M (1995) Study on Alpiniae Fructus. I. Pharmacological evidence of efficacy of Alpiniae Fructus on ancient herbal literature. Yakugaku Zasshi 115(10):852–862. https://doi.org/10.1248/yakushi1947.115.10_852 CrossRefPubMed

Liu RT, Zou LB, JY F, QJ L (2010) Effects of liquiritigenin treatment on the learning and memory deficits induced by amyloid β-peptide (25-35) in rats. Behav Brain Res 210(1):24–31. https://doi.org/10.1016/j.bbr.2010.01.041 CrossRefPubMed

Mao X, Liao ZZ, Guo L, Xu X, Wu B, MJ X, Zhao X, Bi KS, Jia Y (2015) Schisandrin C ameliorates learning and memory deficits by Abeta_1-42-induced oxidative stress and neurotoxicity in mice. Phytother Res 29(9):1373–1380. https://doi.org/10.1002/ptr.5390 CrossRef

Markesbery WR (1997) Oxidative stress hypothesis in Alzheimer's disease. Free Radical Bio Med 23(1):134–147. https://doi.org/10.1016/S0891-5849(96)00629-6 CrossRef

Maurice T, Lockhart BP, Privat A (1996) Amnesia induced in mice by centrally administered β-amyloid peptides involves cholinergic dysfunction. Brain Res 706(2):181–193. https://doi.org/10.1016/0006-8993(95)01032-7 CrossRefPubMed

Nagakannan P, Shivasharan BD, Thippeswamy BS, Veerapur VP, Bansal P (2012) Protective effect of hydroalcoholic extract of Mimusops elengi Linn. flowers against middle cerebral artery occlusion induced brain injury in rats. J Ethnopharmacol 140(2):247–254. https://doi.org/10.1016/j.jep.2012.01.012 CrossRefPubMed

Querfurth HW, LaFerla FM (2010) Mechanisms of disease. New Engl J Med 362(4):329–344. https://doi.org/10.1056/NEJMra0909142 CrossRefPubMed

Rottkamp CA, Raina AK, Zhu X, Gaier E, Bush AI, Atwood CS, Chevion M, Perry G, Smith MA (2001) Redox-active iron mediates amyloid-β toxicity. Free Radical Bio Med 30(4):447–450. https://doi.org/10.1016/S0891-5849(00)00494-9 CrossRef

Shi SH, Zhao X, Liu B, Li H, Liu AJ, Wu B, Bi KS, Jia Y (2014) The effects of Sesquiterpenes-rich extract of Alpinia oxyphylla Miq. on amyloid-β-induced cognitive impairment and neuronal abnormalities in the cortex and hippocampus of mice. Oxidative Med Cell Longev 1:451802

Shi SH, Zhao X, Liu AJ, Liu B, Li H, Wu B, Bi KS, Jia Y (2015) Protective effect of n-butanol extract from Alpinia oxyphylla on learning and memory impairments. Physio Behav 139:13–20. https://doi.org/10.1016/j.physbeh.2014.11.016 CrossRef

Sierksma AS, Rutten K, Sydlik S, Rostamian S, Steinbusch HW, Dl VDH, Prickaerts J (2013) Chronic phosphodiesterase type 2 inhibition improvesmemory in the APPswe/PS1dE9 mouse model of Alzheimer's disease. Neuropharmacology 64:124–136. https://doi.org/10.1016/j.neuropharm.2012.06.048 CrossRefPubMed

Tan R, Chen SL, Yang DJ (2004) Alpinia oxyphylla oil constituents of blood brain barrier permeability GC-MS analysis. Chin Tradit Herbal Drugs 35:624–625

Tesseur I, Pimenova AA, Lo AC, Ciesielska M, Lichtenthaler SF, De Maeyer JH, Schuurkes JAJ, D’Hooge R, De Strooper B (2013) Chronic 5-HT4 receptor activation decreases Aβ production and deposition in hAPP/PS1 mice. Neurobiol Aging 34(7):1779–1789. https://doi.org/10.1016/j.neurobiolaging.2013.01.020 CrossRefPubMed

Wilkinson DG (1991) The parmacology of donepezil: a new treatment of Alzheimer's disease. Exp Opin Pharmacother 1(1):121–135CrossRef

Williams P, Williams P, Sorribas A, Howes MJ (2011) Natural products as a source of Alzheimer's drug leads. Nat Prod Rep 28(1):48–77. https://doi.org/10.1039/C0NP00027B CrossRefPubMed

Wu LD, Tong T, Wan ST, Yan TX, Ren FY, Bi K, Jia Y (2017) Protective effects of puerarin against Abeta_1-42-induced learning and memory impairments in mice. Planta Med 83(3–4):224–231PubMed

Ziech D, Franco R, Georgakilas AG, Georgakila S, Malamou-Mitsi V, Schoneveld O, Pappa A, Panayiotidis MI (2010) The role of reactive oxygen species and oxidative stress in environmental carcinogenesis and biomarker development. Chem Biol Interact 188(2):334–339. https://doi.org/10.1016/j.cbi.2010.07.010 CrossRefPubMed

Titel: Neuroprotective effects of nootkatone from Alpiniae oxyphyllae Fructus against amyloid-β-induced cognitive impairment
verfasst von: Bosai He
Fanxing Xu
Feng Xiao
Tingxu Yan
Bo Wu
Kaishun Bi
Ying Jia
Publikationsdatum: 24.11.2017
Verlag: Springer US
Erschienen in: Metabolic Brain Disease / Ausgabe 1/2018
Print ISSN: 0885-7490
Elektronische ISSN: 1573-7365
DOI: https://doi.org/10.1007/s11011-017-0154-6

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Neurologie

Akuter Schwindel: Wann lohnt sich eine MRT?

28.04.2024 Schwindel Nachrichten

Akuter Schwindel stellt oft eine diagnostische Herausforderung dar. Wie nützlich dabei eine MRT ist, hat eine Studie aus Finnland untersucht. Immerhin einer von sechs Patienten wurde mit akutem ischämischem Schlaganfall diagnostiziert.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Viel Bewegung in der Parkinsonforschung

25.04.2024 Parkinson-Krankheit Nachrichten

Neue arznei- und zellbasierte Ansätze, Frühdiagnose mit Bewegungssensoren, Rückenmarkstimulation gegen Gehblockaden – in der Parkinsonforschung tut sich einiges. Auf dem Deutschen Parkinsonkongress ging es auch viel um technische Innovationen.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2018

Correction to: Contribution of the MRPS22 variant and a Down mosaic to the phenotype

Mitochondrial dysfunctions contribute to energy deficits in rodent model of hepatic encephalopathy

How close are we to therapies for Sanfilippo disease?

Asiatic acid prevents the quinolinic acid-induced oxidative stress and cognitive impairment

Walnut supplementation reverses the scopolamine-induced memory impairment by restoration of cholinergic function via mitigating oxidative stress in rats: a potential therapeutic intervention for age related neurodegenerative disorders

Impact of previous episodes of hepatic encephalopathy on short-term brain function recovery after liver transplantation: a functional connectivity strength study